Skip to main content
logo
Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.1021
-0.0015 (-1.45%)
Oct 19, 2026, 11:55 AM EST

Hepion Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3.19-8.28-13.19-48.93-42.2-32.72
Depreciation & Amortization
--0.030.070.080.09
Other Amortization
--1.27---
Asset Writedown & Restructuring Costs
-0.4-3.191.87-
Stock-Based Compensation
-0.020.791.342.554.67
Other Operating Activities
0.044.09-4.430.47-0.412.31
Change in Accounts Payable
0.270-4.550.32.25-1.07
Change in Other Net Operating Assets
1.280.491.862.670.91-4.5
Operating Cash Flow
-1.59-3.27-18.22-40.89-34.96-31.22
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.01-0.02-0.13
Sale of Property, Plant & Equipment
----0-
Sale (Purchase) of Intangibles
--0.13----
Other Investing Activities
---0.6---
Investing Cash Flow
--0.13-0.6-0.01-0.01-0.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
--3.37----
Long-Term Debt Repaid
------0.18
Total Debt Repaid
-0.37-3.37----0.18
Net Debt Issued (Repaid)
-0.37-3.37----0.18
Issuance of Common Stock
0.794.354.49-82.15
Other Financing Activities
-0.03-0.8---2-
Financing Cash Flow
0.34.834.354.49-5.1481.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
--0.090.01-0.05-
Net Cash Flow
-1.31.42-14.38-36.4-40.1650.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.59-3.27-18.22-40.9-34.98-31.35
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.13-0.35-148.23-515.05-458.85-446.07
Levered Free Cash Flow
-0.42-2.51-14.22-25.88-23.97-15.02
Unlevered Free Cash Flow
-0.41-2.5-14.7-25.87-23.96-15.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.020.02--00
Change in Working Capital
1.550.49-2.682.973.15-5.57